197 related articles for article (PubMed ID: 25770781)
1. Nanomolar inhibitors of Mycobacterium tuberculosis glutamine synthetase 1: synthesis, biological evaluation and X-ray crystallographic studies.
Couturier C; Silve S; Morales R; Pessegue B; Llopart S; Nair A; Bauer A; Scheiper B; Pöverlein C; Ganzhorn A; Lagrange S; Bacqué E
Bioorg Med Chem Lett; 2015 Apr; 25(7):1455-9. PubMed ID: 25770781
[TBL] [Abstract][Full Text] [Related]
2. Functionalized 3-amino-imidazo[1,2-a]pyridines: a novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors.
Odell LR; Nilsson MT; Gising J; Lagerlund O; Muthas D; Nordqvist A; Karlén A; Larhed M
Bioorg Med Chem Lett; 2009 Aug; 19(16):4790-3. PubMed ID: 19560924
[TBL] [Abstract][Full Text] [Related]
3. Trisubstituted imidazoles as Mycobacterium tuberculosis glutamine synthetase inhibitors.
Gising J; Nilsson MT; Odell LR; Yahiaoui S; Lindh M; Iyer H; Sinha AM; Srinivasa BR; Larhed M; Mowbray SL; Karlén A
J Med Chem; 2012 Mar; 55(6):2894-8. PubMed ID: 22369127
[TBL] [Abstract][Full Text] [Related]
4. Computational Sampling and Simulation Based Assessment of Novel Mycobacterium tuberculosis Glutamine Synthetase Inhibitors: Study Involving Structure Based Drug Design and Free Energy Perturbation.
Suryadevara P; Yogeeswari P; Soni V; Devi PB; Nandicoori VK; Sriram D
Curr Top Med Chem; 2016; 16(9):978-95. PubMed ID: 26303425
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonic acids as effective inhibitors of Mycobacterium tuberculosis glutamine synthetase.
Kosikowska P; Bochno M; Macegoniuk K; Forlani G; Kafarski P; Berlicki Ł
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):931-8. PubMed ID: 26235917
[TBL] [Abstract][Full Text] [Related]
6. Identification and synthesis of novel inhibitors of mycobacterium ATP synthase.
Surase YB; Samby K; Amale SR; Sood R; Purnapatre KP; Pareek PK; Das B; Nanda K; Kumar S; Verma AK
Bioorg Med Chem Lett; 2017 Aug; 27(15):3454-3459. PubMed ID: 28587823
[TBL] [Abstract][Full Text] [Related]
7. A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition.
Yang Y; Gao P; Liu Y; Ji X; Gan M; Guan Y; Hao X; Li Z; Xiao C
Bioorg Med Chem Lett; 2011 Jul; 21(13):3943-6. PubMed ID: 21641210
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for the inhibition of Mycobacterium tuberculosis glutamine synthetase by novel ATP-competitive inhibitors.
Nilsson MT; Krajewski WW; Yellagunda S; Prabhumurthy S; Chamarahally GN; Siddamadappa C; Srinivasa BR; Yahiaoui S; Larhed M; Karlén A; Jones TA; Mowbray SL
J Mol Biol; 2009 Oct; 393(2):504-13. PubMed ID: 19695264
[TBL] [Abstract][Full Text] [Related]
9. 1,3-Azoles from ortho-naphthoquinones: synthesis of aryl substituted imidazoles and oxazoles and their potent activity against Mycobacterium tuberculosis.
Moura KC; Carneiro PF; Pinto Mdo C; da Silva JA; Malta VR; de Simone CA; Dias GG; Jardim GA; Cantos J; Coelho TS; da Silva PE; da Silva EN
Bioorg Med Chem; 2012 Nov; 20(21):6482-8. PubMed ID: 23000294
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Samala G; Devi PB; Saxena S; Meda N; Yogeeswari P; Sriram D
Bioorg Med Chem; 2016 Mar; 24(6):1298-307. PubMed ID: 26867485
[TBL] [Abstract][Full Text] [Related]
11. All four Mycobacterium tuberculosis glnA genes encode glutamine synthetase activities but only GlnA1 is abundantly expressed and essential for bacterial homeostasis.
Harth G; Maslesa-Galić S; Tullius MV; Horwitz MA
Mol Microbiol; 2005 Nov; 58(4):1157-72. PubMed ID: 16262797
[TBL] [Abstract][Full Text] [Related]
12. Differential inhibition of adenylylated and deadenylylated forms of M. tuberculosis glutamine synthetase as a drug discovery platform.
Theron A; Roth RL; Hoppe H; Parkinson C; van der Westhuyzen CW; Stoychev S; Wiid I; Pietersen RD; Baker B; Kenyon CP
PLoS One; 2017; 12(10):e0185068. PubMed ID: 28972974
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, molecular docking and anti-mycobacterial evaluation of new imidazo[1,2-a]pyridine-2-carboxamide derivatives.
Jose G; Suresha Kumara TH; Nagendrappa G; Sowmya HB; Sriram D; Yogeeswari P; Sridevi JP; Guru Row TN; Hosamani AA; Sujan Ganapathy PS; Chandrika N; Narendra LV
Eur J Med Chem; 2015 Jan; 89():616-27. PubMed ID: 25462270
[TBL] [Abstract][Full Text] [Related]
14. Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors.
Naidu KM; Nagesh HN; Singh M; Sriram D; Yogeeswari P; Gowri Chandra Sekhar KV
Eur J Med Chem; 2015 Mar; 92():415-26. PubMed ID: 25590862
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Mycobacterium tuberculosis with antisense oligonucleotides to glutamine synthetase mRNA inhibits glutamine synthetase activity, formation of the poly-L-glutamate/glutamine cell wall structure, and bacterial replication.
Harth G; Zamecnik PC; Tang JY; Tabatadze D; Horwitz MA
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):418-23. PubMed ID: 10618433
[TBL] [Abstract][Full Text] [Related]
16. Total synthesis of hirsutellone B via Ullmann-type direct 13-membered macrocyclization.
Uchiro H; Kato R; Arai Y; Hasegawa M; Kobayakawa Y
Org Lett; 2011 Dec; 13(23):6268-71. PubMed ID: 22040033
[TBL] [Abstract][Full Text] [Related]
17. Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads.
Samala G; Devi PB; Nallangi R; Sridevi JP; Saxena S; Yogeeswari P; Sriram D
Bioorg Med Chem; 2014 Mar; 22(6):1938-47. PubMed ID: 24565972
[TBL] [Abstract][Full Text] [Related]
18. One-pot synthesis of new triazole--Imidazo[2,1-b][1,3,4]thiadiazole hybrids via click chemistry and evaluation of their antitubercular activity.
Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2015 Oct; 25(19):4169-73. PubMed ID: 26298500
[TBL] [Abstract][Full Text] [Related]
19. A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors.
Esposito M; Szadocka S; Degiacomi G; Orena BS; Mori G; Piano V; Boldrin F; Zemanová J; Huszár S; Barros D; Ekins S; Lelièvre J; Manganelli R; Mattevi A; Pasca MR; Riccardi G; Ballell L; Mikušová K; Chiarelli LR
ACS Infect Dis; 2017 Jun; 3(6):428-437. PubMed ID: 28475832
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of glutamine synthetase: a potential drug target in Mycobacterium tuberculosis.
Mowbray SL; Kathiravan MK; Pandey AA; Odell LR
Molecules; 2014 Aug; 19(9):13161-76. PubMed ID: 25162957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
